Gilead Sciences Revenue

In the year 2024, Gilead Sciences had annual revenue of $28.75B USD with 6.04% growth. Gilead Sciences had revenue of $7.57B in the quarter ending December 31, 2024, with 6.40% growth.

Revenue

$28.75B

Revenue Growth

+6.04%

P/S Ratio

n/a

Revenue / Employee

$1.63M

Employees

17,600

Market Cap

107.54B GBP

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	28.75B	1.64B	6.04%
Dec 31, 2023	27.12B	-165.00M	-0.60%
Dec 31, 2022	27.28B	-24.00M	-0.09%
Dec 31, 2021	27.31B	2.62B	10.60%
Dec 31, 2020	24.69B	2.24B	9.98%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
AstraZeneca	43.19B
Shell	227.10B
HSBC Holdings	48.93B
Unilever	50.25B
Rio Tinto Group	42.86B
RELX PLC	9.43B
BP p.l.c.	149.68B
British American Tobacco p.l.c.	25.87B

Revenue Rankings